IsoPet® Cancer Treatment

This sweet girl was diagnosed with oral cancer, and thanks to the expertise of Dr. Diana Sanchez at NorthStar VETS, she received IsoPet® Margin Therapy following surgery—targeting the tumor bed to help eliminate any remaining cancer cells. $RDGL

Another successful IsoPet® treatment of a Mast cell tumor which is one of the most common skin cancers affecting 15-25% of all canine skin tumors. Thank you to Dr. Sanchez of NorthStarVets in Robbinsville, NJ for saving Anu’s life! $RDGL

Capital Veterinary Specialists just broke the record for pets treated in one day by successfully treating 8 patients with IsoPet® Precision Radionuclide Therapy™. CVS is using a new Margin Therapy protocol to expand treatment options for cancer care. $RDGL

Business Update: Feb 17, 2026. Please visit our corporate website VivosInc.com to read the full press release. $RDGL @RadioGel @IsoPetForCancer

Our animal cancer division @IsoPetForCancer is pleased to report continued growth for Q1 that will be further highlighted in the upcoming 10Q. Thank you for following our journey to treating cancer a safer and more effective way. $RDGL

Welcome to our newest clinic in El Paso, Texas!

A press release was issued today to summarize the incredible progress of our animal cancer division @IsoPetForCancer signaling growing awareness and demand for this precise, cost-effective alternative to traditional radiation. $RDGL globenewswire.com/news-release/2…

2025 marked a major commercialization milestone for IsoPet® Animal Cancer Division. The number of certified clinics more than doubled, expanding from 8 locations in 2024 to 17 by year-end 2025—clear evidence of accelerating adoption and growing demand. $RDGL

Today is a day to recognize our vets and a perfect time to give a little shout-out to all those forward-thinking vets out there that have come on board with us in 2025 to offer their patients a safer cancer treatment option with IsoPet®

Soft tissue sarcoma is something our vets see often, and it can be unsettling for any pet parent. We put together an easy to follow blog that explains the signs and symptoms so you can stay informed without feeling overwhelmed. isopet.com/a-guide-to-und…

Our new website has launched! IsoPet® is a safer cancer treatment for small and large animals with clinics across the USA. Visit our new website for more details! $RDGL isopet.com

We want to recognize the dedicated and brilliant team working behind the scenes to bring Vivos Inc’s vision to life. Our divisions @RadioGel and @IsoPetForCancer are pushing forward to offer safe and effective treatments for cancer worldwide. $RDGL

2018–2024 we established our technical groundwork for Precision Radionuclide Therapy™ in veterinary care. 2025 is IsoPet’s first operational year as its own division, saving more pets from cancer. 2026 we will implement profitability-focused initiatives.

In 2025 IsoPet® was driven by a simple goal: give pets fighting cancer a better chance. By working with compassionate leaders like Dr. Drygas and Dr. Jehn at CVS, who embrace new technology, we’re giving pets living with cancer new hope. $RDGL

As 2025 winds down, we’re gearing up for a bold 2026. Global expansion is in sight — bringing our Precision Radionuclide Therapy™ to new international markets and advancing the future of cancer care. $RDGL

Our cutting edge cancer treatment, Precision Radionuclide Therapy™ is showing incredible results for this horse Tilly on an inoperable sarcoma! Warning: graphic but heartwarming images below! IsoPet® is changing the way cancer is treated! $RDGL

As mentioned in our Shareholder letter published last week our plans of expanding @RadioGel continue in India with the goal of accelerating the clinical adoption of RadioGel® to generate high quality data to strengthen regulatory submissions. $RDGL

Yesterday we issued a Shareholder Update Letter through Globe NewsWire and the full press release is posted on our website. As mentioned we continue to prioritize IDE approval. To read the full letter please visit VivosInc.com $RDGL

Business Update - We would like to share the link to our Shareholder Update Letter that posted this morning! globenewswire.com/news-release/2…